COEP
Coeptis Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.99
−8.57%Latest reported
- Last report date
- May 14, 2026
- EPS actual
- -$1.11
- EPS estimate
- —
- Revenue actual
- $113.8K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +4.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 14, 2026 | — | -$1.11 | — | $113.8K |
| Mar 19, 2026 | — | -$0.12 | — | $862.0K |
| Nov 13, 2025 | — | -$0.58 | — | $237.4K |
| Aug 14, 2025 | — | -$1.17 | — | $200.7K |
| May 14, 2025 | — | -$1.11 | — | $62.9K |
| Mar 27, 2025 | -$0.80 | -$1.01 | Miss -26.51% | $1.9M |
| Nov 13, 2024 | -$0.05 | -$0.05 | In line | — |
| Aug 16, 2024 | -$0.09 | -$0.08 | Beat 11.11% | — |
| May 9, 2024 | — | -$0.08 | — | — |
| Aug 11, 2023 | -$0.12 | -$0.08 | Beat 33.33% | — |
| May 15, 2023 | — | -$0.46 | — | — |
| Nov 18, 2022 | — | -$0.28 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 14, 2026